A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer
NCT00629057
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Androgen-insensitive Prostate Cancer
Interventions
BIOLOGICAL:
MVA-BN-PRO
BIOLOGICAL:
MVA-BN-PRO
BIOLOGICAL:
MVA-BN-PRO
Sponsor
Bavarian Nordic